RxDoctor Payments DataLook up a doctor →

Audrey Morgan, NP

Nurse Practitioner · Montgomery, ALNPI 1811339252

Payments from drug & device makers

$23,625in general payments, 2019–2025

Across 1,288 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$3K
  • AbbVie$2K
  • Amgen$2K
  • Novartis$2K
  • Neurocrine Biosciences, Inc.$1K
  • Genentech USA, Inc.$971
  • plus $13K from 50 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.132$2,670
AbbVie152$2,303
Amgen(2 entities)91$1,668
Novartis101$1,637
Neurocrine Biosciences, Inc.67$1,333
Genentech USA, Inc.44$971
Pfizer65$959
SK Life Science, Inc.35$938
Acadia Pharmaceuticals Inc56$902
Lundbeck LLC37$784
Acorda Therapeutics, Inc40$744
Lilly USA, LLC53$675
CSL Behring19$671
Johnson & Johnson(2 entities)41$619
Biogen34$538
EMD Serono, Inc.24$446
Takeda Pharmaceuticals U.S.A., Inc.19$426
Argenx US, Inc.22$421
Biohaven Pharmaceuticals, Inc.21$416
Bristol Myers Squibb20$379
Otsuka America Pharmaceutical, Inc.15$363
AstraZeneca(2 entities)15$295
Biohaven Pharmaceutical Holding Company Ltd.18$260
Teva Pharmaceuticals USA, Inc.14$257
Grifols USA, LLC11$251
Eisai Inc.12$245
Catalyst Pharmaceuticals, Inc.11$216
Mallinckrodt Hospital Products Inc.9$211
MDD US Operations, LLC9$184
TG Therapeutics, Inc.9$166
Scilex Pharmaceuticals Inc.9$145
Impel Pharmaceuticals Inc.16$135
Medtronic1$134
Tanabe Pharma America, Inc.7$131
Genentech, Inc.1$115
Sanofi8$112
Jazz Pharmaceuticals Inc.5$81
Axsome Therapeutics, Inc.4$80
Amneal Pharmaceuticals LLC4$79
Neurelis, Inc.4$77
Vanda Pharmaceuticals Inc.4$67
Supernus Pharmaceuticals, Inc.3$66
Ipsen Biopharmaceuticals, Inc3$61
ANI Pharmaceuticals, Inc.2$47
Merz Pharmaceuticals, LLC2$46
Octapharma USA, Inc.2$44
Azurity Pharmaceuticals, Inc.3$42
Sobi, Inc2$36
Akcea Therapeutics, Inc.2$32
Sunovion Pharmaceuticals Inc.2$29
Arbor Pharmaceuticals, Inc.2$27
Cycle Pharmaceuticals Inc1$22
Corium, LLC2$21
Tonix Medicines, Inc.1$19
Zogenix Inc.1$15
Avanir Pharmaceuticals, Inc.1$14

How this compares

$23,625 in reported general payments places this provider in the 95th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama →

Medicare billing

Part B allowed, 2024
$118,605
Medicare patients
416
Services billed
6,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Montgomery

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →